ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

DRTS Alpha Tau Medical Ltd

2.49
0.14 (5.96%)
시간외 거래
최종 업데이트: 06:18:54
15분 지연
기업명 주식 심볼 시장 주식 타입
Alpha Tau Medical Ltd DRTS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.14 5.96% 2.49 06:18:54
개장가 저가 고가 종가 전일 종가
2.43 2.39 2.47 2.49 2.35
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:30GLOBEAlpha Tau to Participate in May Investor Conferences
25/03/202421:50GLOBEAlpha Tau to Present at the Jefferies Radiopharma Innovation..
08/03/202406:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/03/202406:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/03/202406:01GLOBEAlpha Tau Medical Announces Full Year 2023 Financial Results..
26/02/202422:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/02/202422:30GLOBEAlpha Tau to Participate in Barclays 26th Annual Global..
20/12/202323:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202323:15GLOBEAlpha Tau to Present at the 42nd Annual J.P. Morgan..
19/12/202301:09EDGAR2Form 144 - Report of proposed sale of securities
29/11/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202322:30GLOBEAlpha Tau to Participate in Sidoti Small-Cap Conference
28/11/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202322:30GLOBEAlpha Tau Announces Highly Promising Interim Results from..
21/11/202320:18EDGAR2Form 144 - Report of proposed sale of securities
20/11/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202322:30GLOBEAlpha Tau Submits to Japanese PMDA for Pre-Market Approval..
17/11/202306:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202306:30GLOBEAlpha Tau Medical Announces Third Quarter 2023 Financial..
02/11/202306:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202321:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202321:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202321:30GLOBEAlpha Tau Enters Into Long-Term Lease of Site in New..
24/10/202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202322:00GLOBEFormer U.S. Commissioner of Food and Drug Administration..
27/09/202320:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/09/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
14/09/202321:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/09/202321:30GLOBEAlpha Tau Treats First Patient with Advanced Inoperable..
12/09/202305:16EDGAR2Form F-3 - Registration statement by foreign private issuers
29/08/202305:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202305:02GLOBEAlpha Tau Medical Announces Second Quarter 2023 Financial..
24/08/202321:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/08/202306:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/08/202306:00GLOBEAlpha Tau Announces Robust Long-Term Safety and Efficacy..
02/08/202322:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/05/202305:01GLOBEAlpha Tau Medical to Participate in June Investor..
24/05/202305:01GLOBEAlpha Tau Medical Announces First Quarter 2023 Financial..
18/05/202305:30GLOBEAlpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer..
12/05/202305:00GLOBEAlpha Tau Announces the Publication of its US Multicenter..

최근 히스토리

Delayed Upgrade Clock